stockrow
Saturday 7 November 2026
Export AIDX’s income statement to Excel — free account
20/20 Biolabs Inc.
AIDX Healthcare Medical Devices
20/20 Biolabs Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 million, up 16.7% from fiscal 2024.
0.20
0.01
+5.26%
Follow AIDX
Alert me
| Dec '25 | Dec '24 | |
|---|---|---|
P/E ratio |
0.00 | 0.00 |
P/S ratio |
0.00 | 0.00 |
P/FCF ratio |
0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(33.18) | (35.48) |
Beneish M-Score |
(4.35) | — |
P/Operating CF |
(59.91) | (59.91) |
P/B ratio |
0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 |
EV/Operating CF |
(20.70) | (20.70) |
EV/FCF |
(20.70) | (20.70) |
Quick Ratio |
0.50 | 1.42 |
Current Ratio |
0.60 | 1.50 |
Net Debt/EBITDA |
0.11 | 0.32 |
Debt/Assets |
16.77% | 0.00% |
Debt/Equity |
(36.15) | 0.00 |
Asset Turnover |
0.53 | 0.00 |
Operating CF/Net income |
0.51 | 0.47 |
Capex/Depreciation |
0.00 | 0.00 |
Interest Coverage |
(21.32) | (450.59) |
| (537.07%) | 0.00% | |
| (96.84%) | 0.00% | |
ROIC |
0.00% | 0.00% |
Return on Tangible Assets |
399.74% | (697.63%) |
Average Days of Receivables |
35.70 | 28.18 |
Research and Development Expense of Revenue |
28.98% | 72.01% |
Selling, General and Administrative Expense of Revenue |
163.45% | 271.62% |
Intangible Assets out of Total Assets |
0.26 | 0.35 |
Share Based Compensation of Revenue |
25.24% | 124.19% |
Graham Net Nets |
(0.02) | (0.02) |
Graham Number |
0.00 | 0.00 |
Earnings Yield |
(158.71%) | (158.71%) |
Free Cash Flow Yield |
(4.82%) | (4.82%) |
Revenue per Share |
0.41 | 0.37 |
Operating CF per Share |
(0.39) | (0.54) |
Capex per Share |
0.00 | 0.00 |
Free Cash Flow per Share |
(0.39) | (0.54) |
Cash per Share |
0.21 | 0.37 |
Shareholders Equity per Share |
0.00 | 0.31 |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
0.00 | 0.31 |
Free Cash Flow |
(1.92) | (2.60) |
Working Capital |
(0.99) | 0.68 |
Net Current Asset Value |
(2.69) | (0.04) |
EV/EBIT |
0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 |
| Other line items | ||
Depreciation/Fixed assets |
3.41 | 1.21 |
Cash ROIC |
(112.87%) | (79.00%) |
Accounts Receivable Turnover |
12.20 | 0.00 |
Accounts Payable Turnover |
2.32 | 0.00 |
Inventory Turnover |
17.63 | 0.00 |
Average Days of Payables |
220.05 | 97.62 |
Days of Inventory on Hand |
29.44 | 12.38 |
Average Receivables |
0.17 | — |
Average Payables |
0.62 | — |
Average Inventory |
0.08 | — |
Average Assets |
3.86 | — |
Average Common Equity |
0.70 | — |
Columns are period end dates